THX Pharma Société Anonyme Company Description

THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease.

The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025.

The company was founded in 2013 and is headquartered in Lyon, France.

THX Pharma Société Anonyme

Country	France
Founded	2013
Industry	Pharmaceutical Preparations
Employees	10
CEO	Mathieu Charvériat

Contact Details

Address: 60, Avenue Rockefeller Lyon, 69008 France
Phone	33 1 88 89 70 31
Website	theranexus.com

Stock Details

Ticker Symbol	3VG
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	2834

Key Executives

Name	Position
Mathieu Charvériat	Chief Executive Officer
Christine Placet	Chief Financial Officer
Julien Veys	Chief Operating Officer